BioSpace News Archive

On May 17, 2019, the Vertex Pharmaceuticals building development team, including BNBuilders, DGA, and LPA, were honored with a Calibre Design Award in the Healthcare category.

There is a growing preference for OTC drugs as they can be bought without a prescription.

The global influenza diagnostics market is expected to post a CAGR of close to 9% during the period 2019-2023, according to the latest market research report by Technavio.

The global aesthetic lasers and energy devices market is expected to post a CAGR of close to 11% during the period 2019-2023, according to the latest market research report by Technavio.

First Non-Invasive Combined Occipital and Trigeminal Nerve Stimulation Device Charting New Course in Self-Administered Treatment of Migraine

Columbia Care Inc. (“Columbia Care” or the “Company”) (NEO: CCHW, OTC: COLXF), one of the largest fully-integrated operators in the global medical cannabis industry with licenses in 15 jurisdictions across the US and the EU, today announced that it has begun operations in Ohio with the opening of its Level I cultivation facility in Mt. Orab.

During 14–17 July, RaySearch will exhibit its latest advances at the 61st AAPM Annual Meeting in San Antonio, US. The company will demonstrate RayCare® 3A*, the latest release of the groundbreaking oncology information system, and RayStation® 9A*, the new release of the innovative treatment planning system.

InMode Ltd. (“InMode”) today announced it has filed a registration statement on Form F-1 with the U.S. Securities and Exchange Commission (“SEC”) relating to a proposed initial public offering of its ordinary shares.

Sensorion announces that it has received the Investigational New Drug clearance from the US Food and Drug Administration to proceed with SENS-401, based on preclinical data and clinical development plan.

New treatment can help Canadians living with hemophilia A better manage their bleeding episodes